A new exhibition in Budapest features 16 facial reconstructions based on skulls excavated from the ancient city of Aquincum.
(NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review a supplemental New Drug Application (sNDA) for TALZENNA ® (talazoparib), an oral poly ...